The study performed by Medfield Diagnostics AB in cooperation with the Chalmers University of Technology, the Sahlgrenska Academy and the Sahlgrenska University Hospital, has been published in IEEE Transactions on Biomedical Engineering. Below are links to the article and the press releases from the institutions above.
CEO Dag Jungenfelt comments: We are pleased that we now have published, scientific evidence to show the potential of Strokefinder. The results are very positive and indicate that with Strokefinder in the ambulance, the current 4 to 10 percent that receive the right treatment today can be dramatically increased – and at an earlier stage. This strengthens us in our continued talks with future customers and in the work to make Strokefinder available to patients and improve future stroke care.